Skip to content
Live newsroom 27 readers online
Friday, September 4, 2026 Live Sync: Just now
BreakingB.B. King’s journey from Mississippi to ‘King of the Blues’ gets new film
Share Suggestions AVOID GOOGL Stage 4 (Conv: 1/5 | Size: 10%)

Dodgers sit Shohei Ohtani for series finale against Cardinals as health concerns mount

This is read by an automated voice. Please report any issues or inconsistencies here. See more from the L.A. Times in Google Search. Set us as preferred Shohei Ohtani was out of the lineup Thursday and his availability is a “day-to-day situation,” manager Dave Roberts announced before the Dodgers’ series finale against the St. Louis […]

By deepak · September 4, 2026 · 3 min read

This is read by an automated voice. Please report any issues or inconsistencies here.

See more from the L.A. Times in Google Search. Set us as preferred

Shohei Ohtani was out of the lineup Thursday and his availability is a “day-to-day situation,” manager Dave Roberts announced before the Dodgers’ series finale against the St. Louis Cardinals.

Ohtani’s health has been scrutinized for much of the season and even more over the last week. He hasn’t pitched since July 3 because of soreness and threw a bullpen session last Friday in hopes of pitching one inning Sunday against the Detroit Tigers. But, not feeling “100%,” as Roberts put it, Ohtani didn’t return to the mound, and his throwing progression stalled.

Though Roberts described Ohtani’s ailment as an overall issue, including his left knee and right biceps, he remained in the lineup. Roberts said then that he’d been given no indication that swinging the bat was affecting Ohtani, but if that changed, the manager would have no problem with sitting the superstar.

Wednesday, as Ohtani went 0 for 4 in the midst of a two-for-23 skid, seemed to be a turning point.

Shohei Ohtani winced in pain throughout his final at-bat against the Cardinals, who defeated the Dodgers for the second day in a row.

“I saw the same thing that everyone saw,” Roberts said after the Dodgers’ 8-6 loss to the Cardinals. “I saw the shaking of the arm, I saw the wincing, and clearly the swings aren’t who he is. And so, obviously, there’s some compensation. So I’m going to talk to him, and then I’ll make a decision about his availability.”

Roberts said a stint on the injured list was unlikely “but not impossible.”

Ohtani has declined requests for comment through a team spokesperson and hasn’t addressed reporters in more than two weeks.

“He definitely doesn’t want to take the day [off],” Roberts said Wednesday. “Speaking for him, I know he feels that he needs to post and be in the lineup, and if he’s upright, he should play. I respect that. But if he’s feeling the way that it visibly looks, then it’s really not helping anyone. So that’s the conversation I’ll have with him.”

Managing Ohtani’s health will continue to be a priority for the Dodgers. He’s been dealing with lingering knee soreness and inflammation since at least mid-June, and his biceps issue has flared several times this season.

Ohtani’s buildup back to pitching has been halted twice since he received an Orthovisc injection to lubricate the knee joint over the All-Star break.

As valuable as Ohtani is to the Dodgers as a pitcher, his offensive impact is needed far more, especially with left-hander Tarik Skubal added to the rotation. If continuing to try to pitch jeopardizes Ohtani’s production with his bat, it may be in the team’s best interest to take pitching off the table for him.

Tommy Edman was penciled into the leadoff spot and will play center field, while Alex Call will be the designated hitter and bat eighth.

Source: Read the original article on www.latimes.com

Important Legal & Financial Disclaimer

FutureKnowledge is an automated financial intelligence aggregator. The information provided on this website does not constitute investment advice, financial advice, trading advice, or any other sort of advice and you should not treat any of the website's content as such. We are not registered with the SEC, SEBI, or any regulatory agency. Automated AI-generated content may contain errors. Always conduct your own due diligence and consult your financial advisor before making any investment decisions.

© 2026 FutureKnowledge Intelligence. All rights reserved.